Omega Therapeutics to Participate in Two Upcoming Investor Conferences
June 01 2023 - 7:00AM
Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage
biotechnology company pioneering the development of a new class of
programmable epigenomic mRNA medicines, today announced that
management will participate in two upcoming investor conferences.
Jefferies Healthcare Conference
Fireside ChatDate: Thursday, June 8, 2023Time: 8:30
a.m. ET
Goldman Sachs 44th
Annual Global Healthcare ConferenceFireside
ChatDate: Wednesday, June 14, 2023Time: 2:40 p.m. PT /
5:40 p.m. ET
Live webcasts of the fireside chats will be available on the
Investors & Media section of the Company's website
at www.omegatherapeutics.com. Archived replays will be
available on the same website for approximately 90 days.
About Omega Therapeutics
Omega Therapeutics is a clinical-stage biotechnology company
pioneering the development of a new class of programmable
epigenomic mRNA medicines to treat or cure a broad range of
diseases. By pre-transcriptionally modulating gene expression,
Omega’s approach enables precision epigenomic control of nearly all
human genes, including historically undruggable and
difficult-to-treat targets, without altering native nucleic acid
sequences. Founded in 2017 by Flagship Pioneering following
breakthrough research by world-renowned experts in the field of
epigenetics, Omega is led by a seasoned and accomplished leadership
team with a track record of innovation and operational excellence.
The Company is committed to revolutionizing genomic medicine and
has a diverse pipeline of therapeutic candidates derived from its
OMEGA platform spanning oncology, regenerative medicine, multigenic
diseases including immunology, and select monogenic diseases.
For more information, visit omegatherapeutics.com, or
follow us on Twitter and LinkedIn.
Contact:
Eva Stroynowski
617.949.4370
estroynowski@omegatx.com
Omega Therapeutics (NASDAQ:OMGA)
Historical Stock Chart
From Apr 2024 to May 2024
Omega Therapeutics (NASDAQ:OMGA)
Historical Stock Chart
From May 2023 to May 2024